158 related articles for article (PubMed ID: 27685906)
1. The value of calprotectin S100A8/A9 complex as a biomarker in colorectal cancer: A systematic review.
Moris D; Spartalis E; Angelou A; Margonis GA; Papalambros A; Petrou A; Athanasiou A; Schizas D; Dimitroulis D; Felekouras E
J BUON; 2016; 21(4):859-866. PubMed ID: 27685906
[TBL] [Abstract][Full Text] [Related]
2. Calprotectin (S100A8/S100A9): a key protein between inflammation and cancer.
Shabani F; Farasat A; Mahdavi M; Gheibi N
Inflamm Res; 2018 Oct; 67(10):801-812. PubMed ID: 30083975
[TBL] [Abstract][Full Text] [Related]
3. Significance of S100A8, S100A9 and calprotectin levels in bladder cancer.
Yasar O; Akcay T; Obek C; Turegun FA
Scand J Clin Lab Invest; 2017 Oct; 77(6):437-441. PubMed ID: 28609200
[TBL] [Abstract][Full Text] [Related]
4. Calprotectin in rheumatic diseases.
Ometto F; Friso L; Astorri D; Botsios C; Raffeiner B; Punzi L; Doria A
Exp Biol Med (Maywood); 2017 Apr; 242(8):859-873. PubMed ID: 27895095
[TBL] [Abstract][Full Text] [Related]
5. Chronic liver inflammation and hepatocellular carcinogenesis are independent of S100A9.
De Ponti A; Wiechert L; Stojanovic A; Longerich T; Marhenke S; Hogg N; Vogel A; Cerwenka A; Schirmacher P; Hess J; Angel P
Int J Cancer; 2015 May; 136(10):2458-63. PubMed ID: 25331529
[TBL] [Abstract][Full Text] [Related]
6. Clinical and histopathological correlations of fecal calprotectin release in colorectal carcinoma.
Lehmann FS; Trapani F; Fueglistaler I; Terracciano LM; von Flüe M; Cathomas G; Zettl A; Benkert P; Oertli D; Beglinger C
World J Gastroenterol; 2014 May; 20(17):4994-9. PubMed ID: 24803811
[TBL] [Abstract][Full Text] [Related]
7. The role of myofibroblasts in upregulation of S100A8 and S100A9 and the differentiation of myeloid cells in the colorectal cancer microenvironment.
Kim JH; Oh SH; Kim EJ; Park SJ; Hong SP; Cheon JH; Kim TI; Kim WH
Biochem Biophys Res Commun; 2012 Jun; 423(1):60-6. PubMed ID: 22634002
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of S100A8 and S100A9 expression in gastric cancer].
Hu Y; Fan B; Zhang LH; Cheng XJ; Niu ZJ; Ji JF
Zhonghua Yi Xue Za Zhi; 2013 Nov; 93(42):3369-74. PubMed ID: 24418034
[TBL] [Abstract][Full Text] [Related]
9. Involvement of calprotectin (S100A8/A9) in molecular pathways associated with HNSCC.
Khammanivong A; Sorenson BS; Ross KF; Dickerson EB; Hasina R; Lingen MW; Herzberg MC
Oncotarget; 2016 Mar; 7(12):14029-47. PubMed ID: 26883112
[TBL] [Abstract][Full Text] [Related]
10. Calprotectin - a pleiotropic molecule in acute and chronic inflammation.
Stríz I; Trebichavský I
Physiol Res; 2004; 53(3):245-53. PubMed ID: 15209531
[TBL] [Abstract][Full Text] [Related]
11. Prospective evaluation of fecal calprotectin as a screening biomarker for colorectal neoplasia.
Limburg PJ; Devens ME; Harrington JJ; Diehl NN; Mahoney DW; Ahlquist DA
Am J Gastroenterol; 2003 Oct; 98(10):2299-305. PubMed ID: 14572583
[TBL] [Abstract][Full Text] [Related]
12. S100A8 facilitates the migration of colorectal cancer cells through regulating macrophages in the inflammatory microenvironment.
Zha H; Sun H; Li X; Duan L; Li A; Gu Y; Zeng Z; Zhao J; Xie J; Yuan S; Li H; Zhou L
Oncol Rep; 2016 Jul; 36(1):279-90. PubMed ID: 27176480
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic characteristics of S100A8/A9 in a multicenter study of patients with acute right lower quadrant abdominal pain.
Mills AM; Huckins DS; Kwok H; Baumann BM; Ruddy RM; Rothman RE; Schrock JW; Lovecchio F; Krief WI; Hexdall A; Caspari R; Cohen B; Lewis RJ
Acad Emerg Med; 2012 Jan; 19(1):48-55. PubMed ID: 22221415
[TBL] [Abstract][Full Text] [Related]
14. Calprotectin in Lung Diseases.
Kotsiou OS; Papagiannis D; Papadopoulou R; Gourgoulianis KI
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567747
[TBL] [Abstract][Full Text] [Related]
15. Calprotectin and cardiovascular events. A narrative review.
Montagnana M; Danese E; Lippi G
Clin Biochem; 2014 Aug; 47(12):996-1001. PubMed ID: 24625561
[TBL] [Abstract][Full Text] [Related]
16. Calprotectin levels in necrotizing enterocolitis: a systematic review of the literature.
Pergialiotis V; Konstantopoulos P; Karampetsou N; Koutaki D; Gkioka E; Perrea DN; Papantoniou N
Inflamm Res; 2016 Nov; 65(11):847-852. PubMed ID: 27328832
[TBL] [Abstract][Full Text] [Related]
17. Oxidative cross-linking of calprotectin occurs in vivo, altering its structure and susceptibility to proteolysis.
Hoskin TS; Crowther JM; Cheung J; Epton MJ; Sly PD; Elder PA; Dobson RCJ; Kettle AJ; Dickerhof N
Redox Biol; 2019 Jun; 24():101202. PubMed ID: 31015146
[TBL] [Abstract][Full Text] [Related]
18. The role of faecal calprotectin in diagnosis and staging of colorectal neoplasia: a systematic review and meta-analysis.
Ross FA; Park JH; Mansouri D; Combet E; Horgan PG; McMillan DC; Roxburgh CSD
BMC Gastroenterol; 2022 Apr; 22(1):176. PubMed ID: 35397505
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of faecal biomarkers in detecting colorectal cancer and adenoma in symptomatic patients.
Widlak MM; Thomas CL; Thomas MG; Tomkins C; Smith S; O'Connell N; Wurie S; Burns L; Harmston C; Evans C; Nwokolo CU; Singh B; Arasaradnam RP
Aliment Pharmacol Ther; 2017 Jan; 45(2):354-363. PubMed ID: 27910113
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance of the urinary canine calgranulins in dogs with lower urinary or urogenital tract carcinoma.
Heilmann RM; McNiel EA; Grützner N; Lanerie DJ; Suchodolski JS; Steiner JM
BMC Vet Res; 2017 Apr; 13(1):112. PubMed ID: 28431528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
